Resources

  • References


    Bonnema SJ, Bennedbek FN, et al. Management of the nontoxic multinodular goiter: a North American Survey.
    J Clin Endocrinol Metab. 2002;87:112-117.


    Bonnema SJ, Nielsen VE, et al. Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trail.
    J Clin Endo Metab.
    2007;92:3424-3428.


    Diehl LA, Garcia V, Bonnema SJ, et al. Management of the nontoxic multinodular goiter in Latin America: comparison with North America and Europe, an electronic survey.
    J Clin Endocrinol Metab. 2005;90:117-123.


    Freitas JE. Therapeutic options in the management of toxic and nontoxic nodular goiter.
    Seminars in Nuclear Medicine. 2000;30:88-97.


    Hurley DL, Gharib H. Evaluation and management of multinodular goiter.
    Otolaryngol Clin North Am. 1996;29:527-540.


    Kasper DL, et al.
    Harrison’s Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005.

  • Resources

    American Association of Clinical Endocrinologists

    http://www.aace.com

    The American Thyroid Association

    http://www.thyroid.org

    The Hormone Foundation

    http://www.hormone.org

    Thyroid Foundation of America

    http://www.tsh.org

  • Canadian Resources

    Canadian Family Physician

    http://www.cfpc.ca

    Thyroid Foundation of Canada

    http://www.thyroid.ca